Drugs / WT
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05038306 Comparator | May 2021 → Sep 2022 | autosomal dominant cerebellar ataxia | Changhua Christian Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05038306 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The Chinese medicine WT is thought to be neurotrophic, and its major constituent may benefit IGF-1 in animal studies, or certain healthy human group.” NCT05038306 ↗ |